Table 1.
Phase | Category | Intervention | Mastectomy | MIS hysterectomy | Thyroidectomy | MIS prostatectomy |
---|---|---|---|---|---|---|
Preoperative | Optimization of comorbidities | Varies depending on patient’s condition | X | X | X | X |
Patient education | Discussion regarding postoperative course (sore throat, nausea, and pain), ambulation | X | X | X | X | |
Hydration | Clear liquids up to 2 h before scheduled arrival | X | X | X | X | |
PONV prophylaxis | Aprepitant 40 mg orally, for patients with Apfel score of 4 | X | X | X | ||
Multimodal analgesia | Gabapentin 300 mg orally, immediately before surgery | X | X | X | ||
Paravertebral, serratus anterior, and PEC1 block | X | |||||
Intraoperative | Fluid management | 1–3 mL/kg-IBW/h maintenance | X | X | X | Fluid restriction until bladder closure |
Anesthesia | Total intravenous anesthesia | O | O | O | O | |
Multimodal analgesia | Acetaminophen 1 g IV at start | X | X | X | X | |
Ketorolac 15–30 mg IV | X | X | X | |||
Local anesthesia infiltration | X | X | X | X | ||
PONV prophylaxis | Dexamethasone 4 mg IV at start Ondansetron 4 mg IV at end | X | X | X + dexamethasone 8 mg IV | X | |
Intubation recovery | 4% lidocaine 1–2 mL via endotracheal tube at start of closure | X | ||||
Postoperative | Multimodal analgesia | Acetaminophen 1 g orally, every 8 h to maximum 3 g in 24 h | X | X | X | X |
Gabapentin 300 mg orally, at night | X | X | X | |||
Diclofenac 75 mg orally, at night | X | X | X | |||
Postextubation | Benzocaine lozenges | X | ||||
Ambulation | Patients encouraged to walk as soon as they felt able | X | X | X | X | |
Diet | Patients encouraged to resume full diet as soon as they felt able | X | X | X | X |
O indicates optional measures and X indicates standard measures (encouraged but applied at clinicians’ discretion).
Abbreviations: ERAS, enhanced recovery after surgery; IBW, ideal body weight; IV, intravenous; MIS, minimally invasive surgery; PEC1, pectoralis 1; PONV, postoperative nausea.